These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 29446996)

  • 41. [Research progress of CRISPR-Cas9 system for gene therapy].
    Zhan C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome editing comes of age.
    Kim JS
    Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases.
    Wu SS; Li QC; Yin CQ; Xue W; Song CQ
    Theranostics; 2020; 10(10):4374-4382. PubMed ID: 32292501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Transgenic Core Facility's Experience in Genome Editing Revolution.
    Yuan CL; Hu YC
    Adv Exp Med Biol; 2017; 1016():75-90. PubMed ID: 29130154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease.
    Baker C; Hayden MS
    F1000Res; 2020; 9():281. PubMed ID: 32528662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene editing tools: state-of-the-art and the road ahead for the model and non-model fishes.
    Barman HK; Rasal KD; Chakrapani V; Ninawe AS; Vengayil DT; Asrafuzzaman S; Sundaray JK; Jayasankar P
    Transgenic Res; 2017 Oct; 26(5):577-589. PubMed ID: 28681201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CRISPR/Cas9 Genome Editing Tool: A Promising Tool for Therapeutic Applications on Respiratory Diseases.
    Shaikh SB; Bhandary YP
    Curr Gene Ther; 2020; 20(5):333-346. PubMed ID: 33045965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRISPR technologies for bacterial systems: Current achievements and future directions.
    Choi KR; Lee SY
    Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.
    Epstein BE; Schaffer DV
    Adv Exp Med Biol; 2017; 1016():29-42. PubMed ID: 29130152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases.
    Kaur B; Perea-Gil I; Karakikes I
    Curr Cardiol Rep; 2018 Jun; 20(7):58. PubMed ID: 29860642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
    Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
    Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders.
    March OP; Reichelt J; Koller U
    Exp Physiol; 2018 Apr; 103(4):449-455. PubMed ID: 28271571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CRISPR-Cas9 therapies in experimental mouse models of cancer.
    Estêvão D; Rios Costa N; da Costa RG; Medeiros R
    Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Research advances on animal genetics in China in 2015.
    Zhang B; Chen XF; Huang X; Yang X
    Yi Chuan; 2016 Jun; 38(6):467-507. PubMed ID: 27655312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent Progress in Genome Editing for Gene Therapy Applications: The French Perspective.
    Amendola M; Bedel A; Buj-Bello A; Carrara M; Concordet JP; Frati G; Gilot D; Giovannangeli C; Gutierrez-Guerrero A; Laurent M; Miccio A; Moreau-Gaudry F; Sourd C; Valton J; Verhoeyen E
    Hum Gene Ther; 2021 Oct; 32(19-20):1059-1075. PubMed ID: 34494480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.